In conclusion, we performed an in vitro immunotherapy approach based in silencing, by means of PPRHs, PD-1 in macrophages and PD-L1 in different cancer cells in co-culture experiments to inhibit their interaction, thus increasing the phagocytic potency of macrophages against the tumor. This evidence concerns the gene PDCD1 and neoplasm.